Angelina

 

Topic mentions per year

Topic mentions per year

1973-2017
05101519732017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
On May 14, 2013, Angelina Jolie disclosed she carries BRCA1, which means she has an 87% risk of developing breast cancer during… (More)
Is this relevant?
2016
2016
While mutations in BRCA1 and BRCA2 are found in only a minority of breast cancer patients, their impact for those patients is… (More)
Is this relevant?
2015
2015
Purpose:On 14 May 2013, actress Angelina Jolie disclosed that she had a BRCA1 mutation and underwent a prophylactic bilateral… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2015
2015
OBJECTIVE . This study used digital surveillance to examine the impact of Angelina Jolie's prophylactic mastectomy announcement… (More)
  • figure 1
  • figure 2
Is this relevant?
2015
2015
In May 2013 the actress Angelina Jolie informed the press that she had undergone bilateral risk-reducing mastectomy (BRRM… (More)
  • figure 1
Is this relevant?
2015
2015
Movie stars lead glamorous lives, attract enormous attention, and inspire popular lifestyle trends. Angelina Jolie, in particular… (More)
Is this relevant?
2014
2014
Purpose:This study investigates the portrayal of Angelina Jolie’s preventive bilateral mastectomy in the news media. Content… (More)
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
2014
2014
BACKGROUND Accurate risk assessment by general practitioners (GPs) of breast and ovarian cancer for unaffected women with a… (More)
Is this relevant?
2014
2014
Angelina rufescens is placed within the core clade of Rhytismatales (Leotiomycetes, Pezizomycotina, Ascomycota) based on analysis… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2000
2000
  • CAVITY TREES
  • 2000
Over a 13-year period we examined the mortality of cavity trees (n = 453) used by red-cockaded woodpeckers (Picoides bore&) on… (More)
  • table 2
  • table 3
Is this relevant?